Point-of-care testing (POCT) is a growing technology. Today, you may see POCT in a hospital with hand held gadgets or small testers in emergency department, extensive care setting, popular clinical wards and imaging facilities. And market analyses that the world is moving from critical laboratory testing to testing for quick and accurate results at the patient's point of care.
Our MarketsandMarkets virtual conference on Point-of-care technology will cover, the recent development in technologies and products, application of point of care testing in critical care, using it in patient monitoring and scope of it to fight anti-microbial resistance.
The conference aims to bring together speakers from all around the globe, presenters from Pharmaceutical industry and renowned hospitals, and researchers from universities.
Assistant Professor, Fordham University
President & CEO, Co-Founder, Avisa Pharma, USA
Point of Care Testing Co-Ordinator, Einstein Healthcare Network
Lab Supervisor – POCT, Mount Sinai Hospital Health System
Managing Director, Agdia EMEA
Director of Marketing & Quality Manager, Agdia, Inc.
VP Sales International, Sight Diagnostics
POCT Coordinator, Mount Sinai Health System
Chief of Clinical Chemistry and Toxicology, San Francisco, General Hospital
CPHQ, CHRM, Laboratory supervisor, Core Lab, Blood Bank & POCT, Laboratory Medicine & Pathology, Al Dara Hospital & Medical Center, Riyadh, Saudi
Medical Technologist (POINT Of CARE), The King Faisal Specialist Hospital and Research Centre (KFSH&RC)
Professor and Doctorate tutor of Clinical Pharmacology, The Institute of Clinical Pharmacology Qilu Hospital of Shandong.
Director of the Centre for Biosensors, Bioelectronics and Biodevices (C3Bio),Associate Professor, Department of Electronic & Electrical Engineering, University of Bath, University of Bath
Assistant-Chief Medical Technologist (Point-of-Care Testing), McGill University Health Centre, Canada
Director, Program for Neurotrauma, Neuroproteomics and Biomarker Research, University of Florida, USA
